Can a Healthcare Trial Agreement be e-signed?

Yes. Electronic signatures are generally enforceable under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided the parties demonstrate intent, consent, attribution, and retention.

Is a HIPAA BAA required?

If a vendor will access protected health information, a Business Associate Agreement is required under HIPAA and should be executed before PHI is transmitted or stored.

Do I need notarization for execution?

Most trial agreements do not require notarization; however, some institutions or state rules may require notarized signatures for specific attachments or authority documents—verify local policy.

Who can sign for an institution?

Only individuals with delegated authority or explicit signature authority may bind the institution; verify by institution policy and ensure their title appears in the signature block.

How to amend an executed agreement?

Amendments should be in writing, reference the original agreement, and be signed by the same authorized parties unless the agreement permits alternative approval methods.

How long must records be retained?

Follow applicable retention rules: HIPAA requires 6 years (45 CFR §164.530(j)), IRS rules typically 3 years (IRC §6501(a)); adjust for state or sponsor-specific obligations.

Electronic Signature
Templates
Healthcare
Healthcare Trial Agreement

Healthcare Trial Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE TRIAL AGREEMENT

This Healthcare Trial Agreement documents the informed consent and agreement of the participant to enroll in the clinical research study described below. Participant Name: Date of Birth: Gender:

Study Identification

Study Title:

Protocol Number: Sponsor / Funding Entity:

Principal Investigator: Study Site:

Estimated Study Duration per Participant: Anticipated First Visit Date:

Purpose and Procedures

Purpose of the Study: The purpose and objectives of this clinical trial are described below. The participant will undergo the procedures listed and consents to the collection of data and specimens described.

Detailed Description of Procedures Schedule of Visits and Tests

Risks, Benefits, and Alternatives

Known Risks and Potential Discomforts Potential Benefits Alternatives to Participation

Participant Information

Address Primary Phone Emergency Contact

Insurance and Costs

Primary Insurance Provider Policy / Group Number

Participant will be informed in writing of any study-related costs and which costs, if any, will be billed to insurance. Participant agrees that study-related compensation:

Compensation to Participant (if applicable)

Medical History

Current Medications Known Allergies Prior Surgeries / Hospitalizations Chronic or Pre-existing Conditions

Confidentiality and Data Use (HIPAA)

The study will collect, use, and disclose protected health information as necessary to conduct the research. Information will be kept confidential to the extent permitted by law. Data may be transmitted to the sponsor, regulatory agencies, and qualified monitors for oversight and quality assurance.

HIPAA Authorization

By checking the box below, I authorize the use and disclosure of my protected health information for purposes of this study and related oversight.

I authorize the use and disclosure of my health information as described above.

Authorization Expiration Date

Voluntary Participation and Withdrawal

Participation is voluntary. The participant may withdraw at any time without penalty and without loss of benefits to which the participant is otherwise entitled. Withdrawing may not relieve the participant of obligations related to study safety follow-up as required by the investigator.

I understand that I may withdraw from the study at any time.

Samples, Future Research, and Publication

Biological specimens and de-identified data collected for this study may be stored and used for future research or shared with collaborators. Any future use will be governed by applicable law and the terms below.

I consent to storage and future research use of my specimens and de-identified data.

Restrictions on Future Use (optional)

Injury, Compensation, and Liability

In the event of a research-related injury, medical treatment will be made available. Information regarding compensation and treatment for injuries (if provided) will be explained by study staff. Signing this agreement does not waive any legal rights.

Study Contact for Questions or Injury

Participant Certifications

By signing below I certify that I have read and understood the information provided in this agreement, that my questions have been answered to my satisfaction, and that I voluntarily agree to participate in this study.

I have read and understand the information in this document.

My questions have been answered and I have received satisfactory information.

Acknowledgment of Receipt of Documents

I acknowledge receipt of the study information and any supplementary materials provided prior to signing.

I acknowledge receipt of the study information and supplementary materials.

Participant Signature

Printed Name:

Signature:

Date:

If signing for participant, Relationship to Participant:

What a Healthcare Trial Agreement Is and when it applies

A Healthcare Trial Agreement is a written contract that sets the legal, operational, and financial terms between parties conducting a clinical or observational study. It typically covers sponsor and site responsibilities, scope of work, payment or reimbursement, intellectual property, data access, patient privacy protections, indemnification, and termination rights. These agreements govern investigator obligations, study timelines, and deliverables, and may incorporate institutional review board approvals, informed consent language, and data-use restrictions required by HIPAA and other applicable laws.

Why a clear Healthcare Trial Agreement matters

A precise agreement reduces legal ambiguity, protects patient data, clarifies payment and liability, and documents compliance commitments such as HIPAA. It establishes expectations for study conduct and minimizes disputes during enrollment, data collection, or publication.

Who prepares, reviews, and signs these agreements

Coordinated review reduces downstream amendment requests and speeds study start-up when responsibilities are assigned early.

Principal investigators and site research staff who confirm feasibility, resource needs, and protocol adherence.
Sponsored research offices or contract administrators who negotiate payment, indemnity, and IP terms.
Legal counsel and institutional review boards that review consent language and regulatory compliance.

Typical signatories and their roles

Principal Investigator

The clinician or researcher responsible for study conduct, patient safety, and compliance with the protocol and IRB approvals. The investigator attests to site capacity and may sign site-side commitments or delegation of duties statements.

Sponsor Representative

A company or institutional officer authorized to bind the sponsor on budget, indemnity, and IP provisions. This signer accepts financial and regulatory obligations on behalf of the sponsor entity.

Core information to include in the agreement

Parties: Full legal names

Study ID: Protocol number

Effective Date: MM/DD/YYYY

Budget: Payment terms

Data Access: Scope of use

Privacy: HIPAA safeguards

Essential clauses in a professional Healthcare Trial Agreement

A complete agreement organizes obligations clearly and includes sections that reduce regulatory and operational risk for both sponsor and site.

Scope

Defines the protocol, objectives, enrollment targets, and deliverables so both parties share a precise study plan and measurable milestones.

Payment

Specifies per-patient rates, milestone payments, invoicing cadence, expense reimbursement, and audit rights to prevent later disputes over compensation.

Regulatory Compliance

Allocates responsibility for IRB submissions, informed consent, adverse event reporting, and compliance with applicable laws including HIPAA requirements.

Data and IP

Establishes data ownership, permitted uses, publication rights, and intellectual property allocation tied to study results or inventions.

Indemnity and Insurance

Outlines indemnification, liability caps, and required insurance limits to manage risk for injury, breach, or third-party claims.

Termination

Describes termination for convenience, breach, and data disposition obligations, including wind-down assistance and final accounting.

Step-by-step: completing the Healthcare Trial Agreement

Follow this sequence to reduce review cycles and start the study faster.

01

Prepare draft: Populate parties, protocol ID, and budget fields.
02

Internal review: Have legal and finance review for risk and payment terms.
03

IRB coordination: Confirm IRB approval and attach consent documents.
04

Execution: Collect authorized signatures and retain the executed copy.

Typical routing and signatory flow

A predictable routing order helps automate approvals and capture an audit trail for compliance.

Sponsor review: Sponsor legal and contracts approve commercial terms first.
Site review: Site research office confirms budget and resources.
IRB confirmation: IRB signs off on consent and protocol documentation.
Final signatures: Authorized sponsor and site representatives execute the agreement.

Configuring an e-signature workflow for the agreement

Set fields and authentication to match your compliance needs before sending for signatures.

Field	Configuration
Signer authentication	Email + SMS code
Signature fields	Signature, date, printed name
Conditional fields	Show payment schedule after budget approval
Audit trail	Capture IP, timestamp, and action log

Technical considerations for eSubmission and signing

Confirm platform compliance (HIPAA, 21 CFR Part 11 if applicable) and configure signer authentication to match institutional policy.

Formats: PDF or DOCX supported
Integrations: Works with common EHRs and CRMs
Security: TLS 1.2/1.3 and AES-256

Key deadlines and typical processing times

Track these dates to avoid enrollment delays or payment holds during the study lifecycle.

Agreement effective date:

Date execution triggers obligations and payment schedules.

IRB approval date:

Must precede subject enrollment and data collection.

Study start:

First subject enrollment or data collection begins.

Milestone payments:

Payable per contract terms after invoice and verification.

Data lock/closeout:

Final data submission and financial reconciliation date.

Milestone timeline from execution to closeout

A sequential milestone view helps project-manage study start-up and closeout tasks.

01

Execution

Signed agreement becomes binding and triggers site activation tasks.

02

Site initiation

Training, delegation logs, and supplies are completed before enrollment.

03

Enrollment period

Subject recruitment and data collection according to protocol.

04

Closeout

Data lock, final payments, and document archiving occur.

Common mistakes that slow execution

Using inconsistent party names or abbreviations that prevent clear identification and delay countersignature.
Missing IRB or protocol identifiers so sites cannot confirm regulatory readiness before enrollment.
Vague payment language that omits invoicing steps or required documentation for reimbursement.
Failing to specify data access, which leads to disputes over analysis rights and publication.

Risks and potential consequences of errors

Regulatory delay: Enrollment hold

Payment disputes: Withheld invoices

Privacy breach: HIPAA liability

IP disputes: Publication restrictions

Contract termination: Early termination penalties

Reputational harm: Sponsor/site credibility loss

eSignature vendor price and compliance snapshot

High-level pricing and capability comparisons help select a platform that fits budget and compliance needs without implying a recommendation.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-world examples of related deployments

Case examples show how electronic workflows and clear agreements are used in practice across organizations.

Fertility Centers of Illinois

John Butler described faster execution with an integrated e-signature system for clinical documents, supporting multi-site coordination.

The team used centralized templates and API-based routing for consistency.
The change reduced turnaround time for site agreements and improved recordkeeping, aligning signatures with audit trails and institutional compliance needs.

Optica Ventures LLC

Brian Fitzgibbons highlighted simple interfaces that made agreements easier for external partners and internal teams.

Standardized templates and signing links were used for sponsor-site contracts.
The standardized process reduced negotiation cycles, improved version control, and provided clear execution records for audits and sponsor oversight.

Practical tips to speed review and reduce risk

Adopt consistent templates and a centralized review checklist to minimize redlines and ensure regulatory alignment.

Use a master template

Maintain a single controlled Healthcare Trial Agreement template with modular clauses for common variations and institutional approvals.

Pre-assign approvers

Identify legal, finance, and PI approvers early to prevent sequential delays during execution.

Require supporting docs

Attach IRB approval, consent forms, and budget worksheets to the agreement before routing for signature.

Automate retention

Implement a records retention schedule mapped to regulatory obligations to ensure consistent archival and retrieval.

Frequently asked questions about Healthcare Trial Agreements

Answers to common questions about e-signing, notarization, authority to sign, and record retention for clinical agreements.

Need help? Contact support

Can a Healthcare Trial Agreement be e-signed?
Yes. Electronic signatures are generally enforceable under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided the parties demonstrate intent, consent, attribution, and retention.
Is a HIPAA BAA required?
If a vendor will access protected health information, a Business Associate Agreement is required under HIPAA and should be executed before PHI is transmitted or stored.
Do I need notarization for execution?
Most trial agreements do not require notarization; however, some institutions or state rules may require notarized signatures for specific attachments or authority documents—verify local policy.
Who can sign for an institution?
Only individuals with delegated authority or explicit signature authority may bind the institution; verify by institution policy and ensure their title appears in the signature block.
How to amend an executed agreement?
Amendments should be in writing, reference the original agreement, and be signed by the same authorized parties unless the agreement permits alternative approval methods.
How long must records be retained?
Follow applicable retention rules: HIPAA requires 6 years (45 CFR §164.530(j)), IRS rules typically 3 years (IRC §6501(a)); adjust for state or sponsor-specific obligations.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now